Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study.
暂无分享,去创建一个
Kazuhiro Yoshida | M. Azuma | H. Baba | T. Oshima | Y. Omuro | K. Amagai | T. Nishina | K. Shitara | A. Kawazoe | K. Yamaguchi | Y. Komatsu | M. Tsuda | H. Kawakami | H. Hara | T. Esaki | N. Machida | H. Yasui | H. Hosaka | S. Han | Y. Negoro | Shinichi Shiratori